Journals / Turkish Journal of Anaesthesiology and Reanimation / 2022 / Cilt: 50 - Sayı: 1

Cardiovascular Disease, Intensive Care, and Mortality in Coronavirus Disease 2019 Patients: A Meta-Analysis

Pages
S15–S21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, the mean age of the participants in the studies was 60 ± 1.6 years and 52.1% were female.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus-2.
📊
Key Findings & Data:The coronavirus disease 2019 pandemic has imparted an extraordinary burden on the intensive care services, which is likely to echo in pandemic and critical care management globally.
💡
Conclusion & Impact:Overall, the mean age of the participants in the studies was 60 ± 1.6 years and 52.1% were female.
🔬Design:Modeling & Simulation
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus-2. The coronavirus disease 2019 pandemic has imparted an extraordinary burden on the intensive care services, which is likely to echo in pandemic and critical care management globally. We aim to meta-analyze mortality outcomes in cardiovascular disease patients and groups receiving corticosteroids therapy, intensive care admission status during coronavirus disease 2019 hospitalization and groups receiving corticosteroid therapy, and lastly, mortality outcomes in mechanically ventilated patients. Finally, we collate a coronavirus disease 2019 field algorithm for ST-elevation myocardial infarction critical care. Methods: PubMed databases were searched for relevant observational studies with MeSH terms including, “cardiovascular disease,” “COVID-19,” “intensive care,” “mortality,” and “mechanical ventilation.” A random-effect model was used to calculate the risk ratio, using RevMan V5.3. Results: A total of 67 622 patients were included with 10 076 participants in the cardiovascular disease group. Overall, the mean age of the participants in the studies was 60 ± 1.6 years and 52.1% were female. A higher death risk was found in cardiovascular disease patients during and after coronavirus disease 2019 infection (risk ratio = 2.43, 95% CI = 1.74 to 3.41, P < .0001). Mechanical ventilation was likened to worsen mortality rates at any time during the hospital stay (risk ratio = 5.32, 95% CI = 3.89 to 7.29, P < .0001). Publication bias was not observed and high methodological qualities were included. Conclusions: Cardiovascular disease imparts a high burden on intensive care leading to high mortality among coronavirus disease 2019 patients. It is essential that myocardial infarctions in the acute care setting, and conditions such as hypertension and coronary artery diseases, are closely monitored while leading coronavirus disease 2019 hospitalization protocols.

🔖

Cite This Article

SARFRAZ, Z., SARFRAZ, A., SARFRAZ, M., ZIA, I., ALI, M. Z., GARİMELLA, R., TEBHA, S. S., HUSSAIN, H., NADEEM, Z., PATEL, G. (2022). Cardiovascular Disease, Intensive Care, and Mortality in Coronavirus Disease 2019 Patients: A Meta-Analysis. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 50 - Sayı: 1, S15–S21. https://ajindex.com/articles/414174

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71-76. [CrossRef] 2. Ristagno G, Weil MH. History of critical care medicine: the past, the present and the future. In: Intensive and Critical Care Medicine. WFSICCM World Federation of Societies of Intensive and Critical Care Medicine; 2009. 3. Carter C, Notter J. COVID-19 disease: a critical care perspective. Clin Integr Care. 2020;1. [CrossRef] 4. Nicolaou S, Talsky A, Khashoggi K, Venu V. Ultrasoundguided interventional radiology in critical care. Crit Care Med. 2007;35(5):S186-S197. [CrossRef] 5. Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5);2517-2518. [CrossRef] 6. World Health Organization. Cardiovascular Diseases (CVDs): Fact Sheet No. 317. Geneva: WHO Media Centre; 2017. 7. Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543-558. [CrossRef] 8. Fosbøl EL, Butt JH, Østergaard L, et al. Association of angio tensi n-con verti ng enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality. JAMA. 2020;324(2):168-177. [CrossRef] 9. Tarun T, Kumar S, Johnson J, Chockalingam A. A case report on transient cardiomyopathy with cytokine storm in SARS-CoV-2. Eur Heart J Case Rep. 2021;5(2):ytaa519. [CrossRef] 10. Flash MJE, Johnson SF, Jordan M, et al. Disparities in Post- Intensive Care Syndrome During the COVID-19 Pandemic: Challenges and Solutions. NEJM Catal; 2020:1-15. 11. Curtis JR, Kross EK, Stapleton RD. The importance of addressing advance care planning and decisions about do-notresuscitate orders during novel coronavirus 2019 (COVID-19). JAMA. 2020;323(18):1771-1772. [CrossRef] 12. Liu Y, Mao B, Liang S, et al. Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J. 2020;55(5). [CrossRef] 13. Cardona M, Anstey M, Lewis ET, Shanmugam S, Hillman K, Psirides A. Appropriateness of intensive care treatments near the end of life during the covid-19 pandemic. Breathe (Sheff). 2020;16(2):200062. [CrossRef] 14. Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the cardiologist. JACC Basic Transl Sci. 2020;5(5):518-536. [CrossRef] 15. Panebianco N. ACEP COVID-19 field guide. acep.org; 2020. https://www.ac